Search

everythinglearnresearchcommunity

for

Search:↓

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Hair helps prevent scalp skin cancer by supporting immune protection.

Low-level laser therapy shows promise but needs more research for improvement.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

A rare type of skin cancer on the scalp can be mistaken for hair loss, causing delayed diagnosis and severe damage.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Bath PUVA therapy works well for a skin condition without as many cancer risks and is cheaper, and iron deficiency might not cause female hair loss.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Clouston syndrome can lead to skin cancer, so monitoring is crucial.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

The Wnt signaling pathway is essential for skin repair and healing.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

Targeting ornithine decarboxylase can help prevent skin cancer.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

The photolyase-based device significantly changed the size and heat of potential skin cancer areas in patients.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.